Top news of February: Philips Respironics recall, BMI impact on cardiovascular risk in OSA
Healio has compiled the most-read news in pulmonology posted in February.
Highlights include an update to the Philips Respironics recall; the impact BMI has on the risk for major cardiovascular events after acute coronary syndrome due to obstructive sleep apnea (OSA); reduced odds for OSA with high adherence to vegetarian and healthy plant-based diets; a high mortality risk found among individuals who experienced lung function decline after World Trade Center exposure; a Q&A on planned research assessing the usefulness of inpatient sleep tests for patients with sleep-disorder breathing; and more.

Read these and other top stories in pulmonology below:
FDA: More than 500 deaths reportedly connected to recalled Philips Respironics devices
As of Sept. 30, 2023, there have been 561 reported deaths reportedly connected to recalled Philips Respironics devices, according to an update from the FDA. Read more.
Impact of OSA on future cardiovascular events differs by BMI
Among adults with acute coronary syndrome not classified as having obesity, obstructive sleep apnea raised the risk for major cardiovascular and cerebrovascular events, according to results published in CHEST. Read more.
Vegetarian, healthy plant-based diets lower odds for OSA
Consuming a healthy plant-based diet or a pro-vegetarian diet lowers an individual’s likelihood for obstructive sleep apnea, according to results published in ERJ Open Research. Read more.
Lung function decline after World Trade Center exposure raises risk for mortality
Over time, reductions in lung function following exposure to World Trade Center dust heighten the risk for all-cause and cancer-cause mortality, according to results published in Annals of the American Thoracic Society. Read more.
Q&A: Determining usefulness of inpatient sleep tests for sleep-disordered breathing
Individuals with suspected sleep-disordered breathing must undergo sleep testing to be formally diagnosed and treated. However, the benefits of inpatient vs. outpatient sleep assessments are unclear. Healio spoke with Tetyana Kendzerska, MD, PhD, winner of the Research Grant in Sleep Medicine, to learn more about her planned research to assess the usefulness of inpatient sleep tests. Read more.
Chronic, intermittent productive cough linked to poor lung function trajectories
Both a chronic productive cough and an intermittent productive cough were linked to poor lung function trajectories spanning from childhood to adulthood, according to study results published in The Lancet Respiratory Medicine. Read more.
Q&A: Respiratory therapist among top in-demand health care jobs for 2024
Respiratory therapists ranked third on the top five list of most in-demand health care jobs of 2024, according to research conducted by Soliant Health. Healio spoke with Patrick Dotts, senior vice president of Soliant, to learn about the role respiratory therapists play in the health care system and why they are in high demand in 2024. Read more.
Antidepressants raise risk for pneumonia, exacerbation in COPD
Patients with COPD on antidepressants faced a heightened risk for pneumonia and exacerbations, according to results published in Thorax. Read more.
Prenatal fine particulate matter raises odds for severe respiratory distress in newborns
Elevated exposure to fine particulate matter during pregnancy raised the likelihood for assisted ventilation and systemic antibiotics among term newborns, according to results published in Environmental Health Perspectives. Read more.
Mortality differs by year, geography in critically ill pregnant women
Among pregnant women with critical illnesses, in-hospital mortality rates fluctuated by year and geographic location, according to a research letter published in Annals of the American Thoracic Society. Read more.